Pulsenmore sees premarket action after Ouma Health ultrasound agreement
Pulsenmore shares saw premarket volume of 19.19 million—vastly above average—after announcing its FDA-authorized home ultrasound will join Ouma Health’s U.S. virtual maternity care platform, but the deal disclosed no financial terms or patient targets, and Pulsenmore cautioned that results are subject to significant risks.